A Bayesian Industry Approach to Phase 1 Combination Trials in Oncology
2014-10-22 EUGM | ROYCHAUDHURI | Phase I Combination Trials
Phase I dose escalation studies in Oncology: a call for on-study safety and flexibility Bill Mietlowski, Biometrics and Data Management, Novartis Oncology.
